by EpicentRx | Oct 18, 2017 | Conferences
October 2017, Cancun, Mexico Abstract: Radioprotective effects of RRx-001 on the pathophysiology of the hematopoietic system using a murine radiation model
by EpicentRx | Apr 18, 2017 | Conferences
April 2017, Washington, DC. Abstract: The immunomodulatory anticancer agent RRx-001 induces a vaccine-like interferon response through epigenetic induction of viral mimicry Abstract: Epigenetic and biological effects of 5-azacytidine and RRX-001 on DLD-1 colorectal...
by EpicentRx | Apr 18, 2016 | Conferences
April 2016, New Orleans, Louisiana Abstract: Enhanced uptake and accumulation of temozolomide and irinotecan in orthotopically-implanted gliomas by vascular priming with RRx-001 Abstract: RRx-001 is effective in temozolomide-sensitive and resistant GBM Abstract:...
by EpicentRx | Dec 18, 2015 | Conferences
December 2015, Orlando, Florida Oral Presentation: The hypoxia-selective epigenetic agent, RRx-001, triggers apoptosis and overcomes drug-resistance in multiple myeloma cells
by EpicentRx | Nov 18, 2015 | Conferences
November 2015, Boston, Massachusetts Abstract: RRx-001 combined with anti-PD-L1 antibody increases the complete response rate in a preclinical myeloma model
